Charles Cazabon
Director/Board Member at NATRIX Separations, Inc.
Charles Cazabon active positions
Companies | Position | Start | End |
---|---|---|---|
NATRIX Separations, Inc.
NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Director/Board Member | 2010-09-05 | - |
Lactoscience, Inc.
Lactoscience, Inc. Information Technology ServicesTechnology Services Lactoscience, Inc. designs, builds and markets technologies for agri-food by-products. The company was founded in 2011 and is headquartered in Montreal, Canada. | Director/Board Member | - | - |
Career history of Charles Cazabon
Former positions of Charles Cazabon
Companies | Position | Start | End |
---|---|---|---|
BDC Growth Equity Partners
BDC Growth Equity Partners Investment ManagersFinance BDC Growth Equity Partners (BDC Growth) is a Private Equity firm, a subsidiary of Business Development Bank of Canada. The firm is headquartered in Montréal, Canada. | Chief Investment Officer | 2000-12-31 | 2017-06-29 |
Private Equity Investor | 2000-12-31 | 2017-06-29 | |
Réseau Capital
Réseau Capital Miscellaneous Commercial ServicesCommercial Services Réseau Capital operates as a venture capital and private equity association. It promotes private equity industry in Quebec through training, information and promotion, networking, and representation. The company was founded by Jean-Pierre Chartrand in 1989 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | 2005-12-31 | 2007-12-31 |
CDP Capital, Inc.
CDP Capital, Inc. Investment ManagersFinance CDP Capital, Inc. provides investment management services. The company is headquartered in Montreal, Canada. | Private Equity Investor | 1991-12-31 | 2000-12-31 |
viDA Therapeutics, Inc.
viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Director/Board Member | - | - |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Director/Board Member | - | - |
Training of Charles Cazabon
University of Laurentian | Graduate Degree |
The University of Waterloo | Undergraduate Degree |
Richard Ivey School of Business | Masters Business Admin |
Statistics
International
Canada | 11 |
Operational
Director/Board Member | 4 |
Private Equity Investor | 2 |
Graduate Degree | 1 |
Sectoral
Consumer Services | 4 |
Commercial Services | 3 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 7 |
---|---|
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Commercial Services |
Réseau Capital
Réseau Capital Miscellaneous Commercial ServicesCommercial Services Réseau Capital operates as a venture capital and private equity association. It promotes private equity industry in Quebec through training, information and promotion, networking, and representation. The company was founded by Jean-Pierre Chartrand in 1989 and is headquartered in Montréal, Canada. | Commercial Services |
NATRIX Separations, Inc.
NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Health Technology |
BDC Growth Equity Partners
BDC Growth Equity Partners Investment ManagersFinance BDC Growth Equity Partners (BDC Growth) is a Private Equity firm, a subsidiary of Business Development Bank of Canada. The firm is headquartered in Montréal, Canada. | Finance |
Lactoscience, Inc.
Lactoscience, Inc. Information Technology ServicesTechnology Services Lactoscience, Inc. designs, builds and markets technologies for agri-food by-products. The company was founded in 2011 and is headquartered in Montreal, Canada. | Technology Services |
viDA Therapeutics, Inc.
viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Health Technology |
CDP Capital, Inc.
CDP Capital, Inc. Investment ManagersFinance CDP Capital, Inc. provides investment management services. The company is headquartered in Montreal, Canada. | Finance |
- Stock Market
- Insiders
- Charles Cazabon
- Experience